ABOUT US

NEWS

INVESTOR RELATIONS

简 繁 EN
Essex-Bio Group
简 繁 EN
简 繁 EN
INVESTEE NEWS
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
2019.02.28 Download
Related news
Mitotech brings novel approach to treating eye disorders
2021-05-03
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease
2019-07-22
MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
2019-05-14
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
2019-02-28
Essex-Bio Group
BIOTECH
HEALTHTECH
Links
Wuhan Adv.Dental Bio-Technology
UNO Medical Group
Antikor Biopharma
Mitotech S.A.
Henlius
Humacyte
Copyright © 2020 Essex Bio-Technology Limited All Rights Reserved.
Disclaimer | Privacy Policy
粤公网安备 44049102496184号粤ICP备09032349号-1
互联网药品信息服务资格证书编号:（粤）-非经营性-2024-0208 深圳网站建设 深圳联雅
This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
ACCEPT